pI: 8.7487 |
Length (AA): 3021 |
MW (Da): 334027 |
Paralog Number:
0
Signal peptide: N | GPI Anchor: N | Predicted trans-membrane segments: 0
Targets have been classified into druggability groups (DG) according to their druggability score in network driven prioritizations. DGs range from 1 to 5; the higher the group number, the higher the chance of the target to be druggable
Modbase 3D models:
There are 10 models calculated for this protein. More info on
these models, including the
models themselves is available at:
Modbase
Target Beg | Target End | Template | Template Beg | Template End | Identity | Evalue | Model Score | MPQS | zDope |
---|---|---|---|---|---|---|---|---|---|
2475 | 2725 | 1mvh (A) | 195 | 461 | 23.00 | 0 | 1 | -0.01 | 0.77 |
46 | 127 | 1g2d (C) | 108 | 189 | 12.00 | 0.14 | 0 | 0.185943 | -0.8 |
69 | 129 | 2lce (A) | 14 | 74 | 13.00 | 0.48 | 0 | 0.231992 | -1.23 |
824 | 940 | 3s6l (A) | 18 | 132 | 30.00 | 0.099 | 0.49 | 0.327629 | -0.4 |
1622 | 1730 | 3ult (A) | 6 | 118 | 17.00 | 0.94 | 0.02 | 0.159881 | -0.47 |
2328 | 2386 | 2yo0 (A) | 1238 | 1299 | 42.00 | 0.62 | 0.09 | 0.21843 | 1.7 |
2489 | 2737 | 2r3a (A) | 27 | 298 | 24.00 | 0.0000000063 | 1 | 0.246223 | 0.61 |
2578 | 2718 | 3f9x (A) | 199 | 339 | 22.00 | 0.0011 | 0.94 | 0.339473 | -0.54 |
2578 | 2718 | 4ldg (A) | 121 | 264 | 18.00 | 0.7 | 0.88 | 0.271473 | -0.42 |
2879 | 2941 | 1mm2 (A) | 3 | 53 | 45.00 | 0.12 | 0.32 | 0.075754 | 1.87 |
Help me make sense of these data.
A more detailed description of these scores is available at the Modbase Model Evaluation Help Pages, and in the papers referenced therein.
PDB Structures:
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Mid 40-60% percentile | intraerythrocytic - 6 hs, intraerythrocytic - 12 hs, intraerythrocytic - 18 hs, intraerythrocytic - 24 hs, intraerythrocytic - 30 hs, intraerythrocytic - 36 hs, intraerythrocytic - 40 hs, intraerythrocytic - 48 hs. | Zhu L |
Zhu L | New insights into the Plasmodium vivax transcriptome using RNA-Seq. |
Ortholog group members (OG5_128830)
Species | Accession | Gene Product |
---|---|---|
Arabidopsis thaliana | AT1G77300 | histone-lysine N-methyltransferase ASHH2 |
Babesia bovis | BBOV_III009070 | SET domain containing protein |
Brugia malayi | Bm1_35965 | SET domain containing protein |
Candida albicans | CaO19.9324 | likely protein lysine methyltransferase similar to S. cerevisiae SET2 (YJL168C) histone lysine methyltransferase, transcriptiona |
Candida albicans | CaO19.1755 | likely protein lysine methyltransferase similar to S. cerevisiae SET2 (YJL168C) histone lysine methyltransferase, transcriptiona |
Caenorhabditis elegans | CELE_K09F5.5 | Protein SET-12 |
Caenorhabditis elegans | CELE_C43E11.3 | Protein MET-1, isoform B |
Dictyostelium discoideum | DDB_G0268132 | SET domain-containing protein |
Drosophila melanogaster | Dmel_CG1716 | CG1716 gene product from transcript CG1716-RA |
Echinococcus granulosus | EgrG_000452300 | histone lysine N methyltransferase SETD2 |
Echinococcus granulosus | EgrG_000674500 | histone lysine N methyltransferase SETD2 |
Echinococcus multilocularis | EmuJ_000452300 | histone lysine N methyltransferase SETD2 |
Echinococcus multilocularis | EmuJ_000674500 | histone lysine N methyltransferase SETD2 |
Giardia lamblia | GL50803_9130 | Histone methyltransferase HMT1 |
Homo sapiens | ENSG00000181555 | SET domain containing 2 |
Loa Loa (eye worm) | LOAG_03647 | hypothetical protein |
Mus musculus | ENSMUSG00000044791 | SET domain containing 2 |
Neospora caninum | NCLIV_028480 | hypothetical protein |
Oryza sativa | 4329647 | Os02g0554000 |
Plasmodium falciparum | PF3D7_1322100 | histone-lysine N-methyltransferase SET2 |
Plasmodium knowlesi | PKNH_1206700 | histone-lysine N-methyltransferase SET2, putative |
Plasmodium vivax | PVX_116765 | variant-silencing SET protein, putative |
Saccharomyces cerevisiae | YJL168C | Set2p |
Schistosoma japonicum | Sjp_0081690 | IPR001202,WW/Rsp5/WWP,domain-containing |
Schistosoma japonicum | Sjp_0088390 | Histone-lysine N-methyltransferase SETD2, putative |
Schistosoma japonicum | Sjp_0088400 | ko:K01509 adenosinetriphosphatase [EC3.6.1.3], putative |
Schistosoma mansoni | Smp_103090 | hypothetical protein |
Schmidtea mediterranea | mk4.000301.01 | Probable histone-lysine N-methyltransferase CG1716 |
Toxoplasma gondii | TGME49_257770 | histone lysine methyltransferase SET2 |
Theileria parva | TP04_0811 | hypothetical protein |
Gene/Ortholog | Organism | Phenotype | Source Study |
---|---|---|---|
CELE_C43E11.3 | Caenorhabditis elegans | slow growth | wormbase |
CELE_C43E11.3 | Caenorhabditis elegans | sterile | wormbase |
TGME49_257770 | Toxoplasma gondii | Probably essential | sidik |
nmpdr | Genome-scale essentiality datasets from published studies (M. tuberculosis) | National Microbial Pathogen Data Resource |
alsford | High-throughput phenotyping using parallel sequencing of RNA interference targets in the African trypanosome | Genome Res 2011, 21:915-924 |
gerdes | Experimental determination and system-level analysis of essential genes in E. coli MG1655 | Gerdes et al., J Bacteriol. 2003 185:5673-84 |
yeastgenome | Systematic deletion of yeast genes | Saccharomyces Genome Database |
shigen | Profiling of E. coli Chromosome (PEC) | National Institute of Genetics, Japan |
blattner | Systematic mutagenesis of the E. coli (MG1655) genome | J Bacteriol 2004, 186:4921-4930 |
wormbase | C. elegans RNAi experiments | WormBase web site, http://www.wormbase.org, release WS170 |
keio | Systematic single-gene knock-out mutants of E. coli K12 | The Keio Collection |
neb | C. elegans RNAi phenotypes | Data obtained from Wormbase WS150, curated by K. Chaudary and T. Carlow, New England Biolabs |
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
In any case, if you have information about papers containing relevant validation data for this target, please contact us.
Species | Known druggable target | Linked compounds | Reference |
---|---|---|---|
Homo sapiens | SET domain containing 2 | Compounds | References |